Repository logo
 
Publication

Hiperaldosteronismo primário: resultados do primeiro estudo multicêntrico português realizado pelo Grupo de Estudos de Tumores da Supra-Renal

dc.contributor.authorFernandes, V
dc.contributor.authorSilva, T
dc.contributor.authorMartins, D
dc.contributor.authorGonçalves, D
dc.contributor.authorAlmeida, R
dc.contributor.authorMonteiro, AM
dc.contributor.authorNeves, C
dc.contributor.authorSimões, H
dc.contributor.authorMarques, P
dc.contributor.authorSerra, F
dc.contributor.authorPereira, ML
dc.contributor.authorGrupo de Estudos de Tumores da Supra-Renal
dc.date.accessioned2016-07-17T20:44:24Z
dc.date.available2016-07-17T20:44:24Z
dc.date.issued2016
dc.description.abstractIntroduction: Primary Aldosteronism (PA) is the most prevalent cause of secondary hypertension. Nevertheless, there is no portuguese multicenter study characterizing PA patients. Aims: To characterize the clinical presentation, diagnostic workup, treatment and follow-up of patients with confirmed PA. Methods: Retrospective multicenter study of PA patients followed in 9 portuguese hospitals. Results: Sixty-three cases were selected with a mean age of diagnosis of 52.1 ± 13.1 years, 9.9 years after the diagnosis of hypertension. At presentation, 37 cases (60.7%) had hypertension, 11 (22.9%) had resistant hypertension and 20 (32.8%) of patients had hipokalemia (mean 3.2 mmol/L). Baseline laboratory showed a mean serum aldosterone of 33.4ng/dL, plasmatic renin activity (PRA) of 0.2ng/mL/h with an aldosterone/PRA ratio of 97.1. Confirmatory testing was performed with saline infusion in 55 patients (positive in 84.4%) and captopril test in 14 (positive in 85.7%). Imaging showed adenomas in 55 cases, hyperplasia in 2 and bilateral cases in 8. Arterial venous sampling (AVS) was performed in 9 patients (14,5%) and was conclusive in 1. Iodocholesterol scintigraphy was done in 14 cases (22%) with unilateral fixation in 9 and no fixation in 4. Patients were treated with laparoscopic adrenalectomy in 28 cases (58.3%) and mineralocorticoid receptor antagonists in 20 cases (41.7%). The surgical treated group had less duration of hypertension (8 versus 14 years, p = 0.002), higher prevalence of anti-hypertensive drugs at presentation (100 versus 75% p = 0.009) and bigger tumour size (1.8 versus 1.5 cm, p = 0.022). During follow-up there was a trend towards a greater proportion of patients with no hypertension improvement in the medical treatment group (29.4% versus 7.4%, p = 0.089). Conclusion: This is the first Portuguese PA multicenter study. It suggests that PA remains an under- -diagnosed condition with a significant delay in diagnosis. Surgical treated patients had a more aggressive disease and showed a trend towards better hypertension control.pt_PT
dc.identifier.citationRev Port Endocrinol Diabetes Metab. 2016;xxx(xx):xxx–xxxpt_PT
dc.identifier.urihttp://hdl.handle.net/10400.23/1068
dc.language.isoporpt_PT
dc.peerreviewedyespt_PT
dc.subjectHiperaldosteronismopt_PT
dc.subjectAldosteronapt_PT
dc.titleHiperaldosteronismo primário: resultados do primeiro estudo multicêntrico português realizado pelo Grupo de Estudos de Tumores da Supra-Renalpt_PT
dc.title.alternativePrimary Aldosteronism: results from the first Portuguese multicentre study by the adrenal tumour study grouppt_PT
dc.typejournal article
dspace.entity.typePublication
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
HAP.pdf
Size:
351.86 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: